Human Balance ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.7% 9.9% 7.5% 20.5% 19.5%  
Credit score (0-100)  26 25 31 4 5  
Credit rating  BB BB BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  266 374 443 212 279  
EBITDA  -66.2 51.0 116 -114 -47.0  
EBIT  -137 -4.3 60.7 -168 -97.0  
Pre-tax profit (PTP)  -169.8 -19.1 48.0 -179.8 -108.7  
Net earnings  -165.4 -19.1 48.0 -179.8 -108.7  
Pre-tax profit without non-rec. items  -170 -19.1 48.0 -180 -109  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  26.6 21.3 16.0 12.0 12.0  
Shareholders equity total  143 124 172 -8.0 -117  
Interest-bearing liabilities  15.0 7.2 2.6 0.4 94.7  
Balance sheet total (assets)  943 896 884 694 634  

Net Debt  -190 -257 -167 -71.0 30.4  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  266 374 443 212 279  
Gross profit growth  -52.3% 40.3% 18.6% -52.2% 31.8%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  943 896 884 694 634  
Balance sheet change%  -18.7% -5.0% -1.4% -21.5% -8.7%  
Added value  -137.1 -4.3 60.7 -168.0 -97.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -126 -111 -111 -108 -100  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 -1.0 -2.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -51.5% -1.1% 13.7% -79.3% -34.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -13.0% -0.5% 6.8% -21.1% -13.4%  
ROI %  -52.0% -2.9% 39.7% -191.3% -203.8%  
ROE %  -73.3% -14.3% 32.4% -41.5% -16.4%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  15.2% 13.8% 19.4% -1.1% -15.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  287.5% -503.6% -144.3% 62.2% -64.8%  
Gearing %  10.5% 5.8% 1.5% -5.4% -81.2%  
Net interest  0 0 0 0 0  
Financing costs %  91.3% 134.0% 259.2% 836.1% 24.6%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.4 0.5 0.4 0.3 0.3  
Current Ratio  0.7 0.7 0.9 0.7 0.7  
Cash and cash equivalent  205.4 264.2 169.9 71.4 64.3  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -243.2 -207.0 -104.6 -231.5 -262.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -4 61 -168 -97  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 51 116 -114 -47  
EBIT / employee  0 -4 61 -168 -97  
Net earnings / employee  0 -19 48 -180 -109